US Patent Issued to Oregon Health & Science University on Sept. 2 for "PARP inhibitors for treating cancer and asthma" (Oregon Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,250, issued on Sept. 2, was assigned to Oregon Health & Science University (Portland, Ore.).

"PARP inhibitors for treating cancer and asthma" was invented by Michael Cohen (Portland, Ore.) and Ilsa Kirby (Portland, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are substituted 8-methylquinazolin-4(3H)-one compounds useful as PARP inhibitors for the treatment of cancer and asthma, as well as pharmaceutical compositions comprising them and methods for their synthesis."

The patent was filed on June 17, 2024, under Application No. 18/745,664.

*For further information, including images, charts and tables, please visit: http://patft.uspto....